Juno Therapeutics Analysts Recommendations and Consensus

JUNO -- USA Stock  

USD 86.96  0.00  0.00%

The current analyst and expert consensus on Juno Therapeutics is Hold with 7 hold recommendations. The current projected target price consensus is 35.89 with 9 analysts opinions. One of the most common ways Juno Therapeutics analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Juno Therapeutics vendors, executives, and/or customers. Juno Therapeutics recommendation module provides expert sentiment on the projected Juno Therapeutics target price to derive its highest and lowest estimates based on target price standard deviation of 9.739. Please also check Macroaxis Advice on Juno Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Juno Therapeutics Target Price Consensus

Number of Opinions11
Lowered Outlook0
Raized Outlook0
Hold
Macroaxis Recommendation   Exposure   Valuation

Juno Therapeutics Target Price Projection

Current Price

Juno Therapeutics Market Quote
Low Price86.96Odds
High Price86.96Odds

86.96

Target Price

Analyst Consensus On Target Price
Low Estimate24.0Odds
High Estimate51.0Odds
Number of Analysts9
Standard Deviation9.739

35.888

Juno Therapeutics Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Baby Boomer Prospects
Purchased few shares
Traded few hours ago for 79.19
PowerShares QQQ ETF
Purchased few shares
Traded few hours ago for 179.93
Investor Favorites
Purchased few shares
Traded few hours ago for 281.04
Basic Utilities
Sold one share
Traded few hours ago for 42.84
Dividend Beast
Purchased over 90 shares
Traded few hours ago for 45.12
Dividend Beast
Purchased over 90 shares
Traded few hours ago for 61.59
Please also check Macroaxis Advice on Juno Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.